Refractory Evans Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma: Management with a Second Transplantation

Cell Transplantation ◽

Evans Syndrome ◽

Second Transplantation

Faculty Opinions recommendation of Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108297.564322 ◽

2008 ◽

Author(s):

Xavier Leleu

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Plasma Cell ◽

Plasma Cell Disorders

Faculty Opinions recommendation of A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995302.793474247 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Phase 1 ◽

Phase 1 Study

Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation

Expert Opinion on Drug Safety ◽

10.1080/14740338.2021.1945578 ◽

2021 ◽

pp. 1-9

Author(s):

John R Jones ◽

Charlotte Pawlyn ◽

Graham H Jackson

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Maintenance Treatment

Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two‐centre Australian experience

Internal Medicine Journal ◽

10.1111/imj.15182 ◽

2021 ◽

Vol 51 (2) ◽

pp. 280-283

Author(s):

Jeremy Er ◽

David Routledge ◽

Jennifer Hempton ◽

Colin Wood ◽

Trish Joyce ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Australian Experience

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

Blood Cancer Journal ◽

10.1038/s41408-021-00454-y ◽

2021 ◽

Vol 11 (3) ◽

Author(s):

Kalyan Nadiminti ◽

M. Hasib Sidiqi ◽

Kapil Meleveedu ◽

Hassan B. Alkhateeb ◽

William J. Hogan ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Myeloid Neoplasms

Utilization of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.02.026 ◽

2021 ◽

Author(s):

Emily C. Liang ◽

Lori S. Muffly ◽

Parveen Shiraz ◽

Judith A. Shizuru ◽

Laura Johnston ◽

...

Keyword(s):

Stem Cells ◽

Multiple Myeloma ◽

Stem Cell ◽

Autologous Stem Cell Transplantation

Cell Transplantation ◽

Healthcare Resource Utilisation and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients Who Did Not Undergo Autologous Stem Cell Transplantation: Trends in Sweden with the Changing Treatment Landscape

European Journal Of Haematology ◽

10.1111/ejh.13623 ◽

2021 ◽

Author(s):

Fredrik Borgsten ◽

Xenia Gatopoulou ◽

Marta Pisini ◽

Magnus Tambour ◽

Frida Schain ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Sickness Absence ◽

Healthcare Resource ◽

Resource Utilisation ◽

Newly Diagnosed ◽

Healthcare Resource Utilisation

Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy

American Journal of Hematology ◽

10.1002/ajh.26125 ◽

2021 ◽

Author(s):

Kitsada Wudhikarn ◽

Leslie Padrnos ◽

Terra Lasho ◽

Betsy LaPlant ◽

Shaji Kumar ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Cell Transplantation ◽

Prognostic Impact ◽

Clinical Correlates ◽

Clonal Hematopoiesis

The nutrition risk index is associated with bacteremia within 30 days after autologous stem cell transplantation in patients with multiple myeloma

Transplant Infectious Disease ◽

10.1111/tid.13302 ◽

2020 ◽

Vol 22 (4) ◽

Author(s):

Javier Ricardo Garzón Herazo ◽

Oscar Mauricio Muñoz Velandia ◽

Julio Cesar Solano ◽

Luisana Molina Pimienta ◽

Wilmer Javier Figueroa Lemus

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Risk Index ◽

Nutrition Risk

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Leukemia Research ◽

10.1016/j.leukres.2006.09.021 ◽

2007 ◽

Vol 31 (8) ◽

pp. 1069-1075 ◽

Cited By ~ 18

Author(s):

Don M. Benson ◽

Patrick J. Elder ◽

Thomas S. Lin ◽

William Blum ◽

Sam Penza ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Melphalan